US filing for Avastin in first-line ovarian cancer 'unlikely' despite European nod
28 December 2011
Sukaina Virji
Please Login to read the full article.
28 December 2011
Sukaina Virji
Please Login to read the full article.
RELATED CONTENT
NEWS
- Data cast more doubt on Avastin's benefit in older NSCLC patients
- Peregrine holds out for survival data as tepid Phase II PFS in NSCLC vexes market
- Peregrine flies with positive Phase II bavituximab lung cancer data
- US Capitol Capsule: Hope not enough for Avastin in MBC; Hamburg explains withdrawal
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
